JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: In some of these rare cases the diagnosis of a JAK2 V617F-positive disease preceded the acquisition of the Ph-chromosome [35, 36]; in others the second myeloproliferative disease emerged in the remission phase of CML [37–39].